Ads
-
Related paper
- Glucose Transporter 4, Biomarker Development and Metabolic Syndrome in the Arctic
- Uric Acid as a Biomarker of Metabolic Syndrome in Sudanese Adults
- CORRELATION OF THE LEVELS OF THYROID HORMONES WITH VARIOUS COMPONENTS OF METABOLIC SYNDROME IN PATIENTS DIAGNOSED WITH METABOLIC SYNDROME
- Use Of Sodium - Glucose Co - Transporter - 2 Inhibitors In Hospitalized Patients With Acute Heart Failure
- REVIEW ON SODIUM GLUCOSE CO-TRANSPORTER-2 (SGLT2) INHIBITORS: A NEW CLASS OF ANTI-DIABETIC DRUG
- The Emergence of Sodium glucose Co-transporter 2 Inhibitors as a Successful Agent for Management of Diabetes Mellitus
- Placental Glucose Transporter Opportunities to Improve Prognosis Preeclampsia Fetal Outcome in the Future
- Studying The Expression of Glucose Transporter Type 1 in the Histological Grades of Oral Squamous Cell Carcinoma
- Variability of arterial pressure and cardiac rhythm in patients with coronary heart disease and diabetes mellitus: Effect of sodium-glucose co-transporter 2 inhibitor
- Risk and Benefits of Canagliflozin, a New Sodium-Glucose Co-Transporter Type 2 Inhibitor, in the Treatment of type-2 Diabetes Mellitus